PubMed

Cost-effectiveness of anti-retroviral therapy at a district hospital in southern Ethiopia.

Bikilla AD, Jerene D, Robberstad B, Lindtjørn B.

Cost Eff Resour Alloc. 2009 Jul 17;7:13.PMID: 19615069 [PubMed]Free PMC ArticleFree textRelated citations

Cost estimates of HIV care and treatment with and without anti-retroviral therapy at Arba Minch Hospital in southern Ethiopia.

Bikilla AD, Jerene D, Robberstad B, Lindtjorn B.

Cost Eff Resour Alloc. 2009 Apr 13;7:6.PMID: 19364399 [PubMed]Free PMC ArticleFree textRelated citations

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.

Clegg A, Scott DA, Sidhu M, Hewitson P, Waugh N.

Health Technol Assess. 2001;5(32):1-195. Review.PMID: 12065068 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.PMID: 16904047 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Cost and cost-effectiveness of antiretroviral therapy for HIV infection in Singapore.

Paton NI, Chapman CA, Sangeetha S, Mandalia S, Bellamy R, Beck EJ.

Int J STD AIDS. 2006 Oct;17(10):699-705.PMID: 17059641 [PubMed - indexed for MEDLINE]Related citations

Cost-effectiveness of highly active antiretroviral therapy in South Africa.

Badri M, Maartens G, Mandalia S, Bekker LG, Penrod JR, Platt RW, Wood R, Beck EJ.

PLoS Med. 2006 Jan;3(1):e4. Epub 2005 Dec 6.PMID: 16318413 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy.

Freedberg KA, Kumarasamy N, Losina E, Cecelia AJ, Scott CA, Divi N, Flanigan TP, Lu Z, Weinstein MC, Wang B, Ganesh AK, Bender MA, Mayer KH, Walensky RP.

AIDS. 2007 Jul;21 Suppl 4:S117-28.PMID: 17620747 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa--a primary data analysis.

Cleary SM, McIntyre D, Boulle AM.

Cost Eff Resour Alloc. 2006 Dec 6;4:20.PMID: 17147833 [PubMed]Free PMC ArticleFree textRelated citations

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.PMID: 17999842 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Cost-effectiveness analysis of entecavir versus lamivudine in the first-line treatment of Australian patients with chronic hepatitis B.

Arnold E, Yuan Y, Iloeje U, Cook G.

Appl Health Econ Health Policy. 2008;6(4):231-46. doi: 10.2165/00148365-200806040-00005.PMID: 19382822 [PubMed - indexed for MEDLINE]Related citations

Cost effectiveness of adding folinic acid to fluorouracil plus levamisole as adjuvant chemotherapy in patients with colon cancer in Germany.

Monz BU, König HH, Leidl R, Staib L, Link KH.

Pharmacoeconomics. 2003;21(10):709-19.PMID: 12828493 [PubMed - indexed for MEDLINE]Related citations

Cost effectiveness of eplerenone in patients with heart failure after acute myocardial infarction who were taking both ACE inhibitors and beta-blockers: subanalysis of the EPHESUS.

Zhang Z, Mahoney EM, Kolm P, Spertus J, Caro J, Willke R, Weintraub WS.

Am J Cardiovasc Drugs. 2010;10(1):55-63. doi: 10.2165/11319940-000000000-00000.PMID: 20104935 [PubMed - indexed for MEDLINE]Related citations

Cost-effectiveness of routine and low-cost CD4 T-cell count compared with WHO clinical staging of HIV to guide initiation of antiretroviral therapy in resource-limited settings.

Athan E, O'Brien DP, Legood R.

AIDS. 2010 Jul 31;24(12):1887-95.PMID: 20543661 [PubMed - in process]Related citations

A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.PMID: 16904046 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Cost-effectiveness analysis of the addition of rituximab to CHOP in young patients with good-prognosis diffuse large-B-cell lymphoma.

Ferrara F, Ravasio R.

Clin Drug Investig. 2008;28(1):55-65.PMID: 18081361 [PubMed - indexed for MEDLINE]Related citations

Cost effectiveness of combination therapy with pioglitazone for type 2 diabetes mellitus from a german statutory healthcare perspective.

Neeser K, Lübben G, Siebert U, Schramm W.

Pharmacoeconomics. 2004;22(5):321-41. Review.PMID: 15061682 [PubMed - indexed for MEDLINE]Related citations

When to start antiretroviral therapy in resource-limited settings.

Walensky RP, Wolf LL, Wood R, Fofana MO, Freedberg KA, Martinson NA, Paltiel AD, Anglaret X, Weinstein MC, Losina E; CEPAC (Cost-Effectiveness of Preventing AIDS Complications)-International Investigators.

Ann Intern Med. 2009 Aug 4;151(3):157-66. Epub 2009 Jul 20.PMID: 19620143 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

The lifetime cost of current human immunodeficiency virus care in the United States.

Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE, Weinstein MC, Seage GR 3rd, Moore RD, Freedberg KA.

Med Care. 2006 Nov;44(11):990-7. Review.PMID: 17063130 [PubMed - indexed for MEDLINE]Related citations

When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.

Badri M, Cleary S, Maartens G, Pitt J, Bekker LG, Orrell C, Wood R.

Antivir Ther. 2006;11(1):63-72.PMID: 16518961 [PubMed - indexed for MEDLINE]Related citations

Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.

Kang HY, Ko SK, Liew D.

Clin Ther. 2009 Dec;31(12):2919-30; discussion 2916-8.PMID: 20110032 [PubMed - indexed for MEDLINE]Related citations